Hiroo Kuroki

Niigata, 9518510, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications

Selective HDAC6 Inhibition Has the Potential for Anti-Cancer Effect in Renal Cell Carcinoma.

Selective HDAC6 Inhibition Has the Potential for Anti-Cancer Effect in Renal Cell Carcinoma.

Journal: Journal of personalized medicine
Published: May 12, 2024

Targeting Pro-Survival Autophagy Enhanced GSK-3β Inhibition-Induced Apoptosis and Retarded Proliferation in Bladder Cancer Cells.

Targeting Pro-Survival Autophagy Enhanced GSK-3β Inhibition-Induced Apoptosis and Retarded Proliferation in Bladder Cancer Cells.

Journal: Current oncology (Toronto, Ont.)
Published: April 29, 2023

Advanced Bladder Cancer: Changing the Treatment Landscape.

Advanced Bladder Cancer: Changing the Treatment Landscape.

Journal: Journal of personalized medicine
Published: August 29, 2022

Tumor-infiltrating immune cell status predicts successful response to immune checkpoint inhibitors in renal cell carcinoma.

Tumor-infiltrating immune cell status predicts successful response to immune checkpoint inhibitors in renal cell carcinoma.

Journal: Scientific reports
Published: May 03, 2022

Development of patient‑derived tumor organoids and a drug testing model for renal cell carcinoma.

Development of patient‑derived tumor organoids and a drug testing model for renal cell carcinoma.

Journal: Oncology reports
Published: April 01, 2021

Histone deacetylase 6 inhibition in urothelial cancer as a potential new strategy for cancer treatment.

Histone deacetylase 6 inhibition in urothelial cancer as a potential new strategy for cancer treatment.

Journal: Oncology letters
Published: May 07, 2020

Virilization of a female infant genitalia caused by a maternal androgen-producing adrenocortical tumor: A case report.

Virilization of a female infant genitalia caused by a maternal androgen-producing adrenocortical tumor: A case report.

Journal: Urology case reports
Published: April 27, 2020

Clinically relevant GSK‑3β inhibitor 9‑ING‑41 is active as a single agent and in combination with other antitumor therapies in human renal cancer.

Clinically relevant GSK‑3β inhibitor 9‑ING‑41 is active as a single agent and in combination with other antitumor therapies in human renal cancer.

Journal: International journal of molecular medicine
Published: July 08, 2019

9-ING-41, a small molecule inhibitor of GSK-3beta, potentiates the effects of anticancer therapeutics in bladder cancer.

9-ING-41, a small molecule inhibitor of GSK-3beta, potentiates the effects of anticancer therapeutics in bladder cancer.

Journal: Scientific reports
Published: July 01, 2019

Free Tube Graft Urethroplasty for Repair of Hypospadias.

Free Tube Graft Urethroplasty for Repair of Hypospadias.

Journal: Urologia internationalis
Published: June 26, 2019

LONG-TERM OUTCOME OF PEDIATRIC KIDNEY TRANSPLANTATION: A SINGLE-CENTER EXPERIENCES

LONG-TERM OUTCOME OF PEDIATRIC KIDNEY TRANSPLANTATION: A SINGLE-CENTER EXPERIENCES

Journal: Nihon Hinyokika Gakkai zasshi. The japanese journal of urology
Published: January 22, 2019

Ulcerative interstitial cystitis in an adolescent successfully treated with complete transurethral ulcer resection: A case report.

Ulcerative interstitial cystitis in an adolescent successfully treated with complete transurethral ulcer resection: A case report.

Journal: IJU case reports
Published: August 13, 2018
Showing 1-12 of 16

Last Updated: 09/26/2026